US Broker Ratings

Pfizer Inc. (PFE) Stock Analysis: A 7.10% Dividend Yield with Nearly 20% Upside Potential

Pfizer Inc. (NYSE: PFE), a prominent player in the healthcare sector, has long been a cornerstone of the pharmaceutical industry. With a market capitalization of $139.12 billion, Pfizer’s influence stretches..

Waystar Holding Corp. (WAY) Stock Analysis: Unpacking a 31.18% Upside Potential

Waystar Holding Corp. (NASDAQ: WAY) stands out in the healthcare sector with its innovative cloud-based software solutions that streamline healthcare payments. With a market capitalization of $6.35 billion, Waystar is..

Regeneron Pharmaceuticals (REGN): Investor Outlook Reveals 34% Potential Upside Amidst a Diverse Product Portfolio

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is a formidable player in the biotechnology industry, with a significant presence in the healthcare sector. Headquartered in Tarrytown, New York, Regeneron has carved out..

Doximity, Inc. (DOCS) Stock Analysis: Navigating Healthcare’s Digital Frontier with 2% Upside Potential

Doximity, Inc. (NYSE: DOCS), a leading digital platform for healthcare professionals, is capturing investor attention with its robust growth trajectory and burgeoning market presence in the health information services sector...

Haleon plc (HLN) Stock Report: Exploring a 20% Potential Upside with Strong Analyst Ratings

Haleon plc (HLN), a stalwart in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, is turning heads with its potential 20.39% upside, according to analyst ratings...

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating the Upside with a Robust 55.50% Revenue Growth

Blueprint Medicines Corporation (NASDAQ: BPMC), a prominent player in the biotechnology sector, is catching the attention of investors with its impressive revenue growth of 55.50%. As a precision therapy company,..

Medpace Holdings, Inc. (MEDP) Stock Analysis: High ROE and Strategic Growth in Healthcare Research

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a pivotal player in the healthcare sector, specifically within the diagnostics and research industry. With a substantial market capitalization of $8.96 billion, this..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with 35.80% Upside Potential

In the rapidly evolving biotechnology sector, argenx SE (NASDAQ: ARGX) emerges as a prominent player, currently commanding a market capitalization of $34.95 billion. Headquartered in the Netherlands, this commercial-stage biopharmaceutical..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 24.58% Potential Upside

HealthEquity, Inc. (NASDAQ: HQY), a significant player in the healthcare sector, is capturing investor attention with its potential upside of 24.58%. As a leader in health information services, HealthEquity provides..

Revvity, Inc. (RVTY) Stock Analysis: Navigating a 33% Potential Upside in the Healthcare Sector

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, has emerged as a significant investment opportunity with a market capitalization of $10.99 billion. This diagnostics and research company,..

Gilead Sciences, Inc. (GILD) Stock Analysis: Evaluating a 7.9% Upside Amidst Robust Dividends

Gilead Sciences, Inc. (NASDAQ: GILD) stands as a prominent player in the healthcare sector, specifically within the drug manufacturers industry, demonstrating a steadfast commitment to addressing unmet medical needs across..

Fresenius Medical Care AG (FMS) Stock Analysis: Uncovering an 18% Upside Potential

Fresenius Medical Care AG (NYSE: FMS) stands as a significant player in the healthcare sector, particularly within the medical care facilities industry. With a robust market capitalization of $15.91 billion,..

Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating a 20.56% Upside Potential

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, stands as a significant player in the general drug manufacturing industry. Headquartered in Princeton, New Jersey, this biopharmaceutical giant..

Natera, Inc. (NTRA) Stock Analysis: Unpacking a 38.79% Potential Upside in the Diagnostics Powerhouse

Natera, Inc. (NASDAQ: NTRA) has emerged as a compelling player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $18.97 billion, this Austin-based..

Exelixis, Inc. (EXEL) Stock Analysis: Evaluating the 30.6% Revenue Growth and Future Prospects

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, is making waves with its impressive 30.6% revenue growth, capturing the attention of healthcare investors. Specializing in oncology, the..

Thermo Fisher Scientific Inc. (TMO) Stock Analysis: Uncovering a 33.72% Potential Upside Amid Strong Buy Ratings

Thermo Fisher Scientific Inc. (NYSE: TMO), a dominant player in the healthcare sector, particularly in diagnostics and research, has captured the attention of investors with its robust market presence and..

The Cooper Companies, Inc. (COO) Stock Analysis: Examining a 28% Potential Upside in the Healthcare Sector

The Cooper Companies, Inc. (NYSE: COO), a formidable player in the healthcare sector, particularly within the medical instruments and supplies industry, presents a compelling opportunity for individual investors. With a..

Eli Lilly and Company (LLY) Stock Analysis: Robust Growth and 23% Potential Upside Captivate Investors

Eli Lilly and Company (LLY) stands as a powerhouse in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $692.79 billion, the company has established..

Insulet Corporation (PODD) Stock Analysis: A Promising 18% Upside Potential in the Medical Device Sector

Insulet Corporation (NASDAQ: PODD), a leading player in the medical devices industry, is garnering attention from investors eager to tap into the booming healthcare sector. With a market capitalization of..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Growth Potential in the Healthcare Sector

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, continues to capture investor interest with its strategic positioning in the global pharmaceutical industry. Headquartered in Hyderabad,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds